{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:22:06Z","timestamp":1790839326286,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:p>The aim of this study was to evaluate the relationship of hyposmia in Parkinson\u2019s disease (PD) with other motor and non-motor symptoms and with the degree of nigrostriatal dopaminergic cell loss. A total of 295 patients with a diagnosis of PD were included. Olfactory function was measured using the University of Pennsylvania Smell Identification Test (UPSIT). Motor symptoms were rated using the Unified Parkinson\u2019s Disease Rating Scale motor subscale (UPDRS III). To evaluate other non-motor symptoms, we used the Mini-Mental State Examination (MMSE) as a measure of global cognitive function and validated questionnaires to assess sleep disturbances, psychiatric symptoms, and\u00a0autonomic dysfunction. A linear regression model was used to calculate correlation coefficients between UPSIT score and motor and non-motor variables [for psychiatric symptoms a Poisson regression was performed]. In a subgroup of patients (<jats:italic>n<\/jats:italic>\u2009=\u2009155) with a dopamine transporter (DaT) SPECT scan, a similar statistical analysis was performed, now including striatal DaT binding. In the regression models with correction for age, sex, disease duration, and multiple testing, all motor and non-motor symptoms were associated with UPSIT scores. In the subgroup of patients with a DaT-SPECT scan, there was a strong association between olfactory test scores and DaT binding in both putamen and caudate nucleus. Hyposmia in PD is associated with various motor and non-motor symptoms, like cognition, depression, anxiety, autonomic dysfunction and sleep disturbances, and with the degree of nigrostriatal dopaminergic cell loss. This finding adds further confirmation that hyposmia holds significant promise as a marker of disease progression.<\/jats:p>","DOI":"10.1007\/s00702-019-02074-0","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T11:03:02Z","timestamp":1568286182000},"page":"1471-1478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Hyposmia as a marker of (non-)motor disease severity in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-1768","authenticated-orcid":false,"given":"Dareia S.","family":"Roos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. R.","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter G. H. M.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Doty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk W.","family":"Berendse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"2074_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"2074_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893\u2013897","journal-title":"J Consult Clin Psychol"},{"key":"2074_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2011.06.020","volume":"310","author":"HW Berendse","year":"2011","unstructured":"Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson\u2019s disease. J Neurol Sci 310:21\u201324. \n                    https:\/\/doi.org\/10.1016\/j.jns.2011.06.020","journal-title":"J Neurol Sci"},{"key":"2074_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/mds.22155","volume":"23","author":"S Boesveldt","year":"2008","unstructured":"Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ, Berendse HW (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson\u2019s disease. Mov Disord 23:1984\u20131990. \n                    https:\/\/doi.org\/10.1002\/mds.22155","journal-title":"Mov Disord"},{"key":"2074_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00415-006-0284-y","volume":"254","author":"NI Bohnen","year":"2007","unstructured":"Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY (2007) Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson\u2019s disease. J Neurol 254:84\u201390. \n                    https:\/\/doi.org\/10.1007\/s00415-006-0284-y","journal-title":"J Neurol"},{"key":"2074_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/brain\/awq079","volume":"133","author":"NI Bohnen","year":"2010","unstructured":"Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson\u2019s disease. Brain 133:1747\u20131754. \n                    https:\/\/doi.org\/10.1093\/brain\/awq079","journal-title":"Brain"},{"key":"2074_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"2074_CR8","doi-asserted-by":"publisher","first-page":"976589","DOI":"10.1155\/2015\/976589","volume":"2015","author":"S Cavaco","year":"2015","unstructured":"Cavaco S et al (2015) Abnormal olfaction in Parkinson\u2019s disease is related to faster disease progression. Behav Neurol 2015:976589. \n                    https:\/\/doi.org\/10.1155\/2015\/976589","journal-title":"Behav Neurol"},{"key":"2074_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.parkreldis.2015.03.021","volume":"21","author":"W Chen","year":"2015","unstructured":"Chen W et al (2015) Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 21:610\u2013614. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.03.021","journal-title":"Parkinsonism Relat Disord"},{"key":"2074_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2009.09.004","volume":"16","author":"CK Cramer","year":"2010","unstructured":"Cramer CK, Friedman JH, Amick MM (2010) Olfaction and apathy in Parkinson\u2019s disease. Parkinsonism Relat Disord 16:124\u2013126. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2009.09.004","journal-title":"Parkinsonism Relat Disord"},{"key":"2074_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/qjmed\/hcq142","volume":"103","author":"J Deeb","year":"2010","unstructured":"Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ, Hawkes CH (2010) A basic smell test is as sensitive as a dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson\u2019s disease. QJM 103:941\u2013952. \n                    https:\/\/doi.org\/10.1093\/qjmed\/hcq142","journal-title":"QJM"},{"key":"2074_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"2074_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2017.02.017","volume":"38","author":"ME Domellof","year":"2017","unstructured":"Domellof ME, Lundin KF, Edstrom M, Forsgren L (2017) Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 38:41\u201347. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.017","journal-title":"Parkinsonism Relat Disord"},{"key":"2074_CR14","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1474-4422(17)30123-0","volume":"16","author":"RL Doty","year":"2017","unstructured":"Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol 16:478\u2013488. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30123-0","journal-title":"Lancet Neurol"},{"key":"2074_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489\u2013502","journal-title":"Physiol Behav"},{"key":"2074_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","volume":"38","author":"RL Doty","year":"1988","unstructured":"Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237\u20131244","journal-title":"Neurology"},{"key":"2074_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp.55.2.138","volume":"55","author":"RL Doty","year":"1992","unstructured":"Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 55:138\u2013142","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2074_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/neur.1995.0011","volume":"4","author":"RL Doty","year":"1995","unstructured":"Doty RL, Bromley SM, Stern MB (1995) Olfactory testing as an aid in the diagnosis of Parkinson\u2019s disease: development of optimal discrimination criteria. Neurodegeneration 4:93\u201397","journal-title":"Neurodegeneration"},{"key":"2074_CR19","unstructured":"Fahn S, Elton R (1987) UPDRS program members. Unified Parkinson\u2019s disease rating scale recent developments in Parkinson\u2019s disease. vol 2. pp 153\u2013163"},{"key":"2074_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"2074_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2016.02.013","volume":"25","author":"ME Fullard","year":"2016","unstructured":"Fullard ME et al (2016) Olfactory impairment predicts cognitive decline in early Parkinson\u2019s disease. Parkinsonism Relat Disord 25:45\u201351. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.02.013","journal-title":"Parkinsonism Relat Disord"},{"key":"2074_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG et al (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020\u20131028. \n                    https:\/\/doi.org\/10.1002\/mds.20213","journal-title":"Mov Disord"},{"key":"2074_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1212\/WNL.0b013e3181ca014c","volume":"74","author":"DS Goldstein","year":"2010","unstructured":"Goldstein DS, Sewell L, Holmes C (2010) Association of anosmia with autonomic failure in Parkinson disease. Neurology 74:245\u2013251. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181ca014c","journal-title":"Neurology"},{"key":"2074_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","volume":"15","author":"A Haehner","year":"2009","unstructured":"Haehner A et al (2009) Prevalence of smell loss in Parkinson\u2019s disease\u2014a multicenter study Parkinsonism. Relat Disord 15:490\u2013494. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2008.12.005","journal-title":"Relat Disord"},{"key":"2074_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1749-6632.1998.tb10631.x","volume":"855","author":"CH Hawkes","year":"1998","unstructured":"Hawkes CH, Shephard BC (1998) Olfactory evoked responses and identification tests in neurological disease. Ann N Y Acad Sci 855:608\u2013615","journal-title":"Ann N Y Acad Sci"},{"key":"2074_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62:436\u2013446","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2074_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00415-008-0665-5","volume":"255","author":"B Herting","year":"2008","unstructured":"Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson\u2019s disease. J Neurol 255:367\u2013370. \n                    https:\/\/doi.org\/10.1007\/s00415-008-0665-5","journal-title":"J Neurol"},{"key":"2074_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14802\/jmd.14029","volume":"8","author":"JY Hong","year":"2015","unstructured":"Hong JY, Sunwoo MK, Ham JH, Lee JJ, Lee PH, Sohn YH (2015) Apathy and olfactory dysfunction in early Parkinson\u2019s disease J. Mov Disord 8:21\u201325. \n                    https:\/\/doi.org\/10.14802\/jmd.14029","journal-title":"Mov Disord"},{"key":"2074_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/WNL.0000000000001999","volume":"85","author":"DH Lee","year":"2015","unstructured":"Lee DH et al (2015) Is normosmic Parkinson disease a unique clinical phenotype? Neurology 85:1270\u20131275. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001999","journal-title":"Neurology"},{"key":"2074_CR30","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/sleep\/26.8.1049","volume":"26","author":"J Marinus","year":"2003","unstructured":"Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM (2003) Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049\u20131054","journal-title":"Sleep"},{"key":"2074_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8913-9","author":"C Masala","year":"2018","unstructured":"Masala C et al (2018) Correlation among olfactory function, motors\u2019 symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson\u2019s disease. J Neurol. \n                    https:\/\/doi.org\/10.1007\/s00415-018-8913-9","journal-title":"J Neurol"},{"key":"2074_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.22361","volume":"24","author":"T Miyamoto","year":"2009","unstructured":"Miyamoto T, Miyamoto M, Iwanami M, Suzuki K, Inoue Y, Hirata K (2009) Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Mov Disord 24:268\u2013273. \n                    https:\/\/doi.org\/10.1002\/mds.22361","journal-title":"Mov Disord"},{"key":"2074_CR33","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/mds.23792","volume":"26","author":"JF Morley","year":"2011","unstructured":"Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson\u2019s disease. Mov Disord 26:2051\u20132057. \n                    https:\/\/doi.org\/10.1002\/mds.23792","journal-title":"Mov Disord"},{"key":"2074_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ana.20160","volume":"56","author":"MM Ponsen","year":"2004","unstructured":"Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters E, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease. Ann Neurol 56:173\u2013181. \n                    https:\/\/doi.org\/10.1002\/ana.20160","journal-title":"Ann Neurol"},{"key":"2074_CR35","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1093\/brain\/awp244","volume":"132","author":"RB Postuma","year":"2009","unstructured":"Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson\u2019s disease. Brain 132:3298\u20133307. \n                    https:\/\/doi.org\/10.1093\/brain\/awp244","journal-title":"Brain"},{"key":"2074_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/00207450903337721","volume":"120","author":"AL Ramjit","year":"2010","unstructured":"Ramjit AL et al (2010) The relationship between anosmia, constipation, and orthostasis and Parkinson\u2019s disease duration: results of a pilot study. Int J Neurosci 120:67\u201370. \n                    https:\/\/doi.org\/10.3109\/00207450903337721","journal-title":"Int J Neurosci"},{"key":"2074_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","volume":"63","author":"GW Ross","year":"2008","unstructured":"Ross GW et al (2008) Association of olfactory dysfunction with risk for future Parkinson\u2019s disease. Ann Neurol 63:167\u2013173. \n                    https:\/\/doi.org\/10.1002\/ana.21291","journal-title":"Ann Neurol"},{"key":"2074_CR38","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/mds.26276","volume":"30","author":"M Rossi","year":"2015","unstructured":"Rossi M et al (2015) Olfactory dysfunction evaluation is not affected by comorbid depression in Parkinson\u2019s disease. Mov Disord 30:1275\u20131279. \n                    https:\/\/doi.org\/10.1002\/mds.26276","journal-title":"Mov Disord"},{"key":"2074_CR39","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10072-012-1164-0","volume":"34","author":"HY Shin","year":"2013","unstructured":"Shin HY, Joo EY, Kim ST, Dhong HJ, Cho JW (2013) Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder Parkinson\u2019s disease and normal control. Neurol Sci 34:935\u2013940. \n                    https:\/\/doi.org\/10.1007\/s10072-012-1164-0","journal-title":"Neurol Sci"},{"key":"2074_CR40","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000161874.52302.5d","volume":"64","author":"A Siderowf","year":"2005","unstructured":"Siderowf A et al (2005) [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64:1716\u20131720. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000161874.52302.5d","journal-title":"Neurology"},{"key":"2074_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126\u2013137. \n                    https:\/\/doi.org\/10.1093\/brain\/awh322","journal-title":"Brain"},{"key":"2074_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M","volume":"16","author":"G Tissingh","year":"2001","unstructured":"Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC, Wolters EC (2001) Loss of olfaction in de novo and treated Parkinson\u2019s disease: possible implications for early diagnosis. Mov Disord 16:41\u201346","journal-title":"Mov Disord"},{"key":"2074_CR43","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1212\/01.wnl.0000336651.48596.c7","volume":"71","author":"D Verbaan","year":"2008","unstructured":"Verbaan D et al (2008) Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 71:1877\u20131882. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000336651.48596.c7","journal-title":"Neurology"},{"key":"2074_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord 19:1306\u20131312. \n                    https:\/\/doi.org\/10.1002\/mds.20153","journal-title":"Mov Disord"},{"key":"2074_CR45","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson\u2019s disease: the SCOPA-PC. Mov Disord 22:2221\u20132228. \n                    https:\/\/doi.org\/10.1002\/mds.21696","journal-title":"Mov Disord"},{"key":"2074_CR46","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/mds.23664","volume":"26","author":"D Weintraub","year":"2011","unstructured":"Weintraub D, Burn DJ (2011) Parkinson\u2019s disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022\u20131031. \n                    https:\/\/doi.org\/10.1002\/mds.23664","journal-title":"Mov Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-019-02074-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02074-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:30:05Z","timestamp":1599780605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-019-02074-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1007\/s00702-019-02074-0","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R.L. Doty is President of, and major shareholder in Sensonics International, the manufacturer and distributor of smell and taste tests, including the UPSIT.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients had provided written informed consent to store the clinical and imaging data obtained as part of their routine clinical care in a database to be used later for scientific research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}